![]() |
Name |
beta-Longipinene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
2,6,6-trimethyl-9-methylidenetricyclo[5.4.0.02,8]undecane
|
|
SMILES |
CC1(CCCC2(C3C1C2C(=C)CC3)C)C
|
|
InChI |
InChI=1S/C15H24/c1-10-6-7-11-13-12(10)15(11,4)9-5-8-14(13,2)3/h11-13H,1,5-9H2,2-4H3
|
|
InChIKey |
DQOVXHMHLOWECL-UHFFFAOYSA-N
|
|
Synonyms |
beta-Longipinene; (-)-.beta.-Longipinene; CHEBI:192781; 41432-70-6; Q67879725; 2,6,6-trimethyl-9-methylidenetricyclo[5.4.0.0(2,8)]undecane; (1S,2R,7S,8S)-2,6,6-Trimethyl-9-methylenetricyclo[5.4.0.02,8]undecane; Tricyclo[5.4.0.02,8]undecane, 2,6,6-trimethyl-9-methylene-, (1S,2R,7S,8S)-
|
|
CAS | NA | |
PubChem CID | 25203064 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 4.9 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 15 | QED Weighted: | 0.491 |
Caco-2 Permeability: | -4.639 | MDCK Permeability: | 0.00001310 |
Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.213 |
30% Bioavailability (F30%): | 0.056 |
Blood-Brain-Barrier Penetration (BBB): | 0.89 | Plasma Protein Binding (PPB): | 90.65% |
Volume Distribution (VD): | 1.202 | Fu: | 6.15% |
CYP1A2-inhibitor: | 0.276 | CYP1A2-substrate: | 0.714 |
CYP2C19-inhibitor: | 0.293 | CYP2C19-substrate: | 0.918 |
CYP2C9-inhibitor: | 0.358 | CYP2C9-substrate: | 0.681 |
CYP2D6-inhibitor: | 0.036 | CYP2D6-substrate: | 0.841 |
CYP3A4-inhibitor: | 0.186 | CYP3A4-substrate: | 0.279 |
Clearance (CL): | 11.722 | Half-life (T1/2): | 0.049 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.169 |
Drug-inuced Liver Injury (DILI): | 0.172 | AMES Toxicity: | 0.032 |
Rat Oral Acute Toxicity: | 0.519 | Maximum Recommended Daily Dose: | 0.752 |
Skin Sensitization: | 0.064 | Carcinogencity: | 0.05 |
Eye Corrosion: | 0.02 | Eye Irritation: | 0.552 |
Respiratory Toxicity: | 0.762 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000956 | ![]() |
0.556 | D0L2LS | ![]() |
0.277 | ||
ENC001299 | ![]() |
0.518 | D0D2VS | ![]() |
0.275 | ||
ENC002553 | ![]() |
0.464 | D0U3GL | ![]() |
0.275 | ||
ENC002141 | ![]() |
0.462 | D0Z1XD | ![]() |
0.275 | ||
ENC002221 | ![]() |
0.448 | D0H1QY | ![]() |
0.273 | ||
ENC002256 | ![]() |
0.448 | D04VIS | ![]() |
0.267 | ||
ENC001469 | ![]() |
0.441 | D04DJN | ![]() |
0.266 | ||
ENC003145 | ![]() |
0.426 | D0K0EK | ![]() |
0.266 | ||
ENC003118 | ![]() |
0.414 | D06XMU | ![]() |
0.266 | ||
ENC003350 | ![]() |
0.400 | D07BSQ | ![]() |
0.265 |